Supplementary files: Long term safety of nine systemic medications for psoriasis: a cohort study using the Biobadaderm Registry

Supplementary Table 1S. Crude incidence rate ratios and adjusted incidence rate ratios of the adverse effects for each drug. Supplementary Table 2S. Detailed adverse events for each drug compared to MTX. Only those AE included in groups with a decreased rate ratio (IRR < 1, green in Table 3) and highly increased rate ratio (IRR > 5, red in Table 3) are shown.补充表1S：各药物不良反应的粗发病率比与校正发病率比。 补充表2S：各药物与甲氨蝶呤（Methotrexate，MTX）对比的详细不良事件（Adverse Event，AE）。仅展示纳入发病率比降低（IRR < 1，即表3中的绿色标记）组与发病率比大幅升高（IRR > 5，即表3中的红色标记）组的不良事件。